Endostatin inhibits VEGF-A induced osteoclastic bone resorption <it>in vitro</it>
<p>Abstract</p> <p>Background</p> <p>Endostatin is a C-terminal fragment of collagen XVIII which is a component of basement membranes with the structural properties of both collagens and proteoglycans. Endostatin has a major role in angiogenesis which is intimately asso...
Main Authors: | Ilvesaro Joanna, Hautala Timo, Nelo Katri, Sipola Annina, Tuukkanen Juha |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-07-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/7/56 |
Similar Items
-
Effects of vascular endothelial growth factor (VEGF-A) and endostatin on bone
by: Sipola, A. (Annina)
Published: (2009) -
Connexin-mimetic peptide Gap 27 decreases osteoclastic activity
by: Tuukkanen Juha, et al.
Published: (2001-12-01) -
In vitro osteoclast resorption of calcium phosphate bone substitutes
by: Martin, Joanne
Published: (2015) -
Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo
by: Sun P, et al.
Published: (2020-10-01) -
PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption
by: Eunjin Cho, et al.
Published: (2019-09-01)